Show source-provided references
1. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
10.1016/S0140-6736(12)61729-2 ↗2. European Spine Society--the AcroMed Prize for Spinal Research 1995. Unexpected load and asymmetric posture as etiologic factors in low back pain
10.1007/BF00307824 ↗4. Lefevre-Colau, M.M., Fayad, F., Rannou, F., Fermanian, J., Coriat, F., Mace, Y., Revel, M., and Poiraudeau, S. (2009). Frequency and interrelations of risk factors for chronic low back pain in a primary care setting. PLoS ONE, 4.
10.1371/journal.pone.0004874 ↗8. Critical aspects and challenges for intervertebral disc repair and regeneration-Harnessing advances in tissue engineering
10.1002/jsp2.1029 ↗9. Human cartilaginous endplate degeneration is induced by calcium and the extracellular calcium-sensing receptor in the intervertebral disc
10.22203/eCM.v032a09 ↗10. Endplate calcification and cervical intervertebral disc degeneration: The role of endplate marrow contact channel occlusion
10.5603/FM.2015.0014 ↗13. Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc
10.1007/s00586-013-2767-8 ↗14. The role of the physicochemical environment in determining disc cell behaviour
10.1042/bst0300858 ↗18. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues
10.1002/art.27444 ↗20. Autophagy in rat annulus fibrosus cells: Evidence and possible implications
10.1186/ar3443 ↗25. TNF-alpha in nucleus pulposus induces sensory nerve growth: A study of the mechanism of discogenic low back pain using TNF-alpha-deficient mice
10.1097/BRS.0b013e318178e5ea ↗26. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration
10.1186/ar1732 ↗27. TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc
10.1074/jbc.M111.264549 ↗28. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: An in situ zymographic and gene therapy study
10.1186/ar2282 ↗29. Cytokine profile in degenerated painful intervertebral disc: Variability with respect to duration of symptoms and type of disease
10.1016/j.spinee.2016.03.019 ↗30. Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes
10.1053/joca.2002.0789 ↗32. Tumor necrosis factor alpha- and interleukin-1beta-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1
10.1002/art.37819 ↗33. Cell-based therapies for intervertebral disc and cartilage regeneration- Current concepts, parallels, and perspectives
10.1002/jor.23268 ↗34. Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: Recommendations of the ORS spine section
10.1002/jsp2.1036 ↗35. Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: An observational first-in-human trial
10.1016/S0140-6736(16)31658-0 ↗36. Autologous nasal chondrocytes delivered by injectable hydrogel for in vivo articular cartilage regeneration
10.1007/s10561-017-9649-y ↗37. Three-dimensional tissue engineering of hyaline cartilage: Comparison of adult nasal and articular chondrocytes
10.1089/10763270260424178 ↗38. In vitro extracellular matrix accumulation of nasal and articular chondrocytes for intervertebral disc repair
10.1016/j.tice.2017.05.002 ↗39. Rapid Chondrocyte Isolation for Tissue Engineering Applications: The Effect of Enzyme Concentration and Temporal Exposure on the Matrix Forming Capacity of Nasal Derived Chondrocytes
10.1155/2017/2395138 ↗41. Biochemical methods for the analysis of tissue-engineered cartilage
42. Determination of hydroxyproline in tissues and the evaluation of the collagen content of the tissues
43. Potential roles of cytokines and chemokines in human intervertebral disc degeneration: Interleukin-1 is a master regulator of catabolic processes
10.1016/j.joca.2015.02.017 ↗45. An organ culture system to model early degenerative changes of the intervertebral disc
10.1186/ar3494 ↗46. Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1beta, TNF-alpha and TGF-beta
10.1016/j.joca.2006.04.015 ↗47. Differential effects of tumor necrosis factor-alpha and interleukin-1beta on cell death in human articular chondrocytes
10.1016/j.joca.2007.10.006 ↗49. Bone Marrow Stem Cells in Response to Intervertebral Disc-Like Matrix Acidity and Oxygen Concentration: Implications for Cell-based Regenerative Therapy
10.1097/BRS.0000000000001314 ↗50. Nucleus pulposus mesenchymal stem cells in acidic conditions mimicking degenerative intervertebral discs give better performance than adipose tissue-derived mesenchymal stem cells
10.1159/000369452 ↗51. Blockade of acid-sensing ion channels protects articular chondrocytes from acid-induced apoptotic injury
10.1007/s00011-011-0414-6 ↗52. Control of matrix synthesis in isolated bovine chondrocytes by extracellular and intracellular pH
10.1002/jcp.1041640305 ↗55. Acid-sensing ion channel 1a mediates acid-induced increases in intracellular calcium in rat articular chondrocytes
10.1007/s11010-010-0412-y ↗56. Acidic pH promotes intervertebral disc degeneration: Acid-sensing ion channel -3 as a potential therapeutic target
10.1038/srep37360 ↗57. Acid-sensing ion channel 3 decreases phosphorylation of extracellular signal-regulated kinases and induces synoviocyte cell death by increasing intracellular calcium
10.1186/ar4577 ↗59. Effect of extracellular ph on matrix synthesis by chondrocytes in 3D agarose gel
10.1021/bp060024v ↗62. Impaired glycolytic metabolism causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8 translocation into nucleus
10.1016/j.joca.2013.01.013 ↗63. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: A requisite for tissue engineering of intervertebral disc
10.22203/eCM.v008a06 ↗